+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Dermatology CRO Market Size, Share & Trends Analysis Report by Type (Drug Discovery, Preclinical, Clinical), by Service (Clinical Monitoring, Project Management/Clinical Supply Management, Data Management), by Region, and Segment Forecasts, 2025-2033- Product Image
Dermatology CRO Market Size, Share & Trends Analysis Report by Type (Drug Discovery, Preclinical, Clinical), by Service (Clinical Monitoring, Project Management/Clinical Supply Management, Data Management), by Region, and Segment Forecasts, 2025-2033- Product Image
New

Dermatology CRO Market Size, Share & Trends Analysis Report by Type (Drug Discovery, Preclinical, Clinical), by Service (Clinical Monitoring, Project Management/Clinical Supply Management, Data Management), by Region, and Segment Forecasts, 2025-2033

  • PDF Icon

    Report

  • 120 Pages
  • August 2025
  • Region: Global
  • Grand View Research
  • ID: 5457617
Description Jump to:
The global dermatology CRO market size was estimated at USD 5.42 billion in 2024 and is projected to reach USD 9.09 billion by 2033, growing at a CAGR of 5.80% from 2025 to 2033. The dermatology contract research organization (CRO) market is experiencing robust growth, primarily driven by the rising prevalence of chronic skin conditions such as psoriasis, eczema, acne, and skin cancers across the globe.

Besides, growing interest of dermatological companies and increasing awareness of dermatological health, coupled with the expansion of the biopharmaceutical pipeline for innovative topical and systemic therapies is further driving the demand for specialized clinical research services. In addition, factors such as growing investments in dermatology R&D, the rising adoption of personalized medicine, and enhanced patient participation facilitated by digital tools are expected to support the market growth.

Moreover, the emerging trends such as decentralized clinical trials, tele dermatology, and AI-powered skin imaging are reshaping the dermatology clinical trial landscape, improving patient access and data accuracy. The increased use of wearable skin sensors and advanced imaging technologies is further enhancing real-time monitoring and endpoint assessment. Overall, the market scenario is favorable due to rising government initiatives supporting dermatology research, expanding applications in cosmetic dermatology, and increased clinical trial activity in emerging regions like Asia-Pacific and Latin America.

Furthermore, the CROs are taking strategic initiatives such as expanding their geographic presence, forming partnerships with technology providers, and investing in integrated digital platforms to offer comprehensive dermatology trial solutions. In addition, technology advancements, including AI and machine learning for lesion analysis, decentralized trial platforms, and the integration of real-world data, enable CROs to enhance trial efficiency, patient engagement, and data quality, strengthening their competitive position in this dynamic market.

Global Dermatology CRO Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. The analyst has segmented the global dermatology CRO market report based on type, service, and region.

Type Outlook (Revenue, USD Million, 2021-2033)

  • Drug Discovery
  • Target Validation
  • Lead Identification
  • Lead optimization
  • Preclinical
  • Clinical
  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Service Outlook (Revenue, USD Million, 2021-2033)

  • Project Management/Clinical Supply Management
  • Data Management
  • Regulatory/Medical Affairs
  • Medical Writing
  • Clinical Monitoring
  • Quality Management/ Assurance
  • Bio-statistics
  • Investigator Payments
  • Laboratory
  • Patient and Site Recruitment
  • Technology
  • Others

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Sweden
  • Denmark
  • Norway
  • Asia-Pacific
  • Japan
  • China
  • India
  • Thailand
  • South Korea
  • Australia
  • Latin America
  • Brazil
  • Argentina
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Argentina
  • UAE
  • Kuwait

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the industry across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segmental and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Service
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information Or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.7.2. Value-Chain-Based Sizing & Forecasting
1.7.3. Multivariate Model Analysis
1.8. List of Secondary Sources
1.9. List of Abbreviations
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Dermatology CRO Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising Prevalence of Chronic and Complex Skin Disorders
3.2.1.2. Increasing Adoption of Advanced Technologies
3.2.1.3. Growing Demand for Aesthetic Dermatology and Cosmeceuticals
3.2.1.4. Increasing Outsourcing of R&D Activities
3.2.1.5. Favorable Environment for Clinical Trials in Developing Countries
3.2.2. Market Restraint Analysis
3.2.2.1. Quality Issues of CRO Services
3.2.2.2. Intellectual Property Rights Issues
3.3. Pricing Model Analysis
3.4. Technology Landscape
3.5. Market Analysis Tools
3.5.1. Porter’s Five Force Analysis
3.5.2. PESTEL by SWOT Analysis
3.5.3. COVID-19 Impact Analysis
Chapter 4. Dermatology CRO Market: Type Estimates & Trend Analysis
4.1. Dermatology CRO Market, by Type: Segment Dashboard
4.2. Dermatology CRO Market, by Type: Movement Analysis
4.3. Dermatology CRO Market Estimates & Forecasts, by Type, 2021-2033 (USD Million)
4.4. Drug Discovery
4.4.1. Drug Discovery Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2. Target Validation
4.4.2.1. Target Validation Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.3. Lead Identification
4.4.3.1. Lead Identification Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.4. Lead Optimization
4.4.4.1. Lead Optimization Market Estimates and Forecasts, 2021-2033 (USD Million)
4.5. Preclinical
4.5.1. Preclinical Market Estimates and Forecasts, 2021-2033 (USD Million)
4.6. Clinical
4.6.1. Clinical Market Estimates and Forecasts, 2021-2033 (USD Million)
4.6.2. Phase I
4.6.2.1. Phase I Market Estimates and Forecasts, 2021-2033 (USD Million)
4.6.3. Phase II
4.6.3.1. Phase II Market Estimates and Forecasts, 2021-2033 (USD Million)
4.6.4. Phase III
4.6.4.1. Phase III Market Estimates and Forecasts, 2021-2033 (USD Million)
4.6.5. Phase IV
4.6.5.1. Phase IV Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 5. Dermatology CRO Market: Service Estimates & Trend Analysis
5.1. Dermatology CRO Market, by Service: Segment Dashboard
5.2. Dermatology CRO Market, by Service: Movement Analysis
5.3. Dermatology CRO Market Estimates & Forecasts, by Service, 2021-2033 (USD Million)
5.4. Project Management/Clinical Supply Management
5.4.1. Project Management/Clinical Supply Management Market Estimates and Forecasts, 2021-2033 (USD Million)
5.5. Data Management
5.5.1. Data Management Market Estimates and Forecasts, 2021-2033 (USD Million)
5.6. Regulatory/Medical Affairs
5.6.1. Regulatory/Medical Affairs Market Estimates and Forecasts, 2021-2033 (USD Million)
5.7. Medical Writing
5.7.1. Medical Writing Market Estimates and Forecasts, 2021-2033 (USD Million)
5.8. Clinical Monitoring
5.8.1. Clinical Monitoring Market Estimates and Forecasts, 2021-2033 (USD Million)
5.9. Quality Management/ Assurance
5.9.1. Quality Management/ Assurance Market Estimates and Forecasts, 2021-2033 (USD Million)
5.10. Bio-statistics
5.10.1. Bio-statistics Market Estimates and Forecasts, 2021-2033 (USD Million)
5.11. Investigator Payments
5.11.1. Investigator Payments Market Estimates and Forecasts, 2021-2033 (USD Million)
5.12. Laboratory
5.12.1. Laboratory Market Estimates and Forecasts, 2021-2033 (USD Million)
5.13. Patient and Site Recruitment
5.13.1. Patient and Site Recruitment Market Estimates and Forecasts, 2021-2033 (USD Million)
5.14. Technology
5.14.1. Technology Market Estimates and Forecasts, 2021-2033 (USD Million)
5.15. Others
5.15.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 6. Dermatology CRO Market: Regional Estimates & Trend Analysis
6.1. Regional Market Dashboard
6.2. Regional Market Share Analysis, 2024 & 2033
6.3. North America
6.3.1. North America Market Estimates and Forecasts, 2021-2033 (USD Million)
6.3.2. U.S
6.3.2.1. Key Country Dynamics
6.3.2.2. Competitive Scenario
6.3.2.3. Regulatory Framework
6.3.2.4. U.S. Market Estimates and Forecasts, 2021-2033 (USD Million)
6.3.3. Canada
6.3.3.1. Key Country Dynamics
6.3.3.2. Competitive Scenario
6.3.3.3. Regulatory Framework
6.3.3.4. Canada Market Estimates and Forecasts, 2021-2033 (USD Million)
6.3.4. Mexico
6.3.4.1. Key Country Dynamics
6.3.4.2. Competitive Scenario
6.3.4.3. Regulatory Framework
6.3.4.4. Mexico Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4. Europe
6.4.1. Europe Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.2. UK
6.4.2.1. Key Country Dynamics
6.4.2.2. Competitive Scenario
6.4.2.3. Regulatory Framework
6.4.2.4. UK Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.3. Germany
6.4.3.1. Key Country Dynamics
6.4.3.2. Competitive Scenario
6.4.3.3. Regulatory Framework
6.4.3.4. Germany Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.4. France
6.4.4.1. Key Country Dynamics
6.4.4.2. Competitive Scenario
6.4.4.3. Regulatory Framework
6.4.4.4. France Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.5. Italy
6.4.5.1. Key Country Dynamics
6.4.5.2. Competitive Scenario
6.4.5.3. Regulatory Framework
6.4.5.4. Italy Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.6. Spain
6.4.6.1. Key Country Dynamics
6.4.6.2. Competitive Scenario
6.4.6.3. Regulatory Framework
6.4.6.4. Spain Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.7. Denmark
6.4.7.1. Key Country Dynamics
6.4.7.2. Competitive Scenario
6.4.7.3. Regulatory Framework
6.4.7.4. Denmark Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.8. Sweden
6.4.8.1. Key Country Dynamics
6.4.8.2. Competitive Scenario
6.4.8.3. Regulatory Framework
6.4.8.4. Sweden Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.9. Norway
6.4.9.1. Key Country Dynamics
6.4.9.2. Competitive Scenario
6.4.9.3. Regulatory Framework
6.4.9.4. Norway Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5. Asia-Pacific
6.5.1. Asia-Pacific Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.2. Japan
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory Framework
6.5.2.4. Japan Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.3. China
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Regulatory Framework
6.5.3.4. China Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.4. India
6.5.4.1. Key Country Dynamics
6.5.4.2. Competitive Scenario
6.5.4.3. Regulatory Framework
6.5.4.4. India Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.5. Thailand
6.5.5.1. Key Country Dynamics
6.5.5.2. Competitive Scenario
6.5.5.3. Regulatory Framework
6.5.5.4. Thailand Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.6. South Korea
6.5.6.1. Key Country Dynamics
6.5.6.2. Competitive Scenario
6.5.6.3. Regulatory Framework
6.5.6.4. South Korea Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.7. Australia
6.5.7.1. Key Country Dynamics
6.5.7.2. Competitive Scenario
6.5.7.3. Regulatory Framework
6.5.7.4. Australia Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6. Latin America
6.6.1. Latin America Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6.2. Brazil
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory Framework
6.6.2.4. Brazil Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6.3. Argentina
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory Framework
6.6.3.4. Argentina Market Estimates and Forecasts, 2021-2033 (USD Million)
6.7. MEA
6.7.1. MEA Market Estimates and Forecasts, 2021-2033 (USD Million)
6.7.2. South Africa
6.7.2.1. Key Country Dynamics
6.7.2.2. Competitive Scenario
6.7.2.3. Regulatory Framework
6.7.2.4. South Africa Market Estimates and Forecasts, 2021-2033 (USD Million)
6.7.3. Saudi Arabia
6.7.3.1. Key Country Dynamics
6.7.3.2. Competitive Scenario
6.7.3.3. Regulatory Framework
6.7.3.4. Saudi Arabia Market Estimates and Forecasts, 2021-2033 (USD Million)
6.7.4. UAE
6.7.4.1. Key Country Dynamics
6.7.4.2. Competitive Scenario
6.7.4.3. Regulatory Framework
6.7.4.4. UAE Market Estimates and Forecasts, 2021-2033 (USD Million)
6.7.5. Kuwait
6.7.5.1. Key Country Dynamics
6.7.5.2. Competitive Scenario
6.7.5.3. Regulatory Framework
6.7.5.4. Kuwait Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Market Participant Categorization
7.1.1. Market Leaders
7.1.2. Emerging Players
7.2. Company Market Share/Assessment Analysis, 2024
7.3. Company Profiles
7.3.1. IQVIA Inc.
7.3.1.1. Company Overview
7.3.1.2. Financial Performance
7.3.1.3. Service Benchmarking
7.3.1.4. Strategic Initiatives
7.3.2. Labcorp Drug Development
7.3.2.1. Company Overview
7.3.2.2. Financial Performance
7.3.2.3. Service Benchmarking
7.3.2.4. Strategic Initiatives
7.3.3. Thermo Fisher Scientific Inc. (PPD)
7.3.3.1. Company Overview
7.3.3.2. Financial Performance
7.3.3.3. Service Benchmarking
7.3.3.4. Strategic Initiatives
7.3.4. Parexel International Corp.
7.3.4.1. Company Overview
7.3.4.2. Financial Performance
7.3.4.3. Service Benchmarking
7.3.4.4. Strategic Initiatives
7.3.5. Charles River Laboratories
7.3.5.1. Company Overview
7.3.5.2. Financial Performance
7.3.5.3. Service Benchmarking
7.3.5.4. Strategic Initiatives
7.3.6. ICON, Plc
7.3.6.1. Company Overview
7.3.6.2. Financial Performance
7.3.6.3. Service Benchmarking
7.3.6.4. Strategic Initiatives
7.3.7. Syneos Health
7.3.7.1. Company Overview
7.3.7.2. Financial Performance
7.3.7.3. Service Benchmarking
7.3.7.4. Strategic Initiatives
7.3.8. Pharmaron
7.3.8.1. Company Overview
7.3.8.2. Financial Performance
7.3.8.3. Service Benchmarking
7.3.8.4. Strategic Initiatives
7.3.9. Aragen Life Sciences Ltd.
7.3.9.1. Company Overview
7.3.9.2. Financial Performance
7.3.9.3. Service Benchmarking
7.3.9.4. Strategic Initiatives
7.3.10. Wuxi AppTec
7.3.10.1. Company Overview
7.3.10.2. Financial Performance
7.3.10.3. Service Benchmarking
7.3.10.4. Strategic Initiatives
7.3.11. MEDPACE
7.3.11.1. Company Overview
7.3.11.2. Financial Performance
7.3.11.3. Service Benchmarking
7.3.11.4. Strategic Initiatives
7.3.12. CTI Clinical Trial & Consulting
7.3.12.1. Company Overview
7.3.12.2. Financial Performance
7.3.12.3. Service Benchmarking
7.3.12.4. Strategic Initiatives
7.3.13. Bioskin
7.3.13.1. Company Overview
7.3.13.2. Financial Performance
7.3.13.3. Service Benchmarking
7.3.13.4. Strategic Initiatives
7.3.14. Proinnovera GmbH
7.3.14.1. Company Overview
7.3.14.2. Financial Performance
7.3.14.3. Service Benchmarking
7.3.14.4. Strategic Initiatives
7.3.15. Biorasi, LLC
7.3.15.1. Company Overview
7.3.15.2. Financial Performance
7.3.15.3. Service Benchmarking
7.3.15.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Dermatology CRO Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 4 Global Dermatology CRO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 5 Global Dermatology CRO Market Estimates and Forecasts, by Region, 2021-2033 (USD Million)
Table 6 North America Dermatology CRO Market Estimates and Forecasts, by Country, 2021-2033 (USD Million)
Table 7 North America Dermatology CRO Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 8 North America Dermatology CRO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 9 U.S. Dermatology CRO Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 10 U.S. Dermatology CRO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 11 Canada Dermatology CRO Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 12 Canada Dermatology CRO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 13 Mexico Dermatology CRO Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 14 Mexico Dermatology CRO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 15 Europe Dermatology CRO Market Estimates and Forecasts, by Country, 2021-2033 (USD Million)
Table 16 Europe Dermatology CRO Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 17 Europe Dermatology CRO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 18 UK Dermatology CRO Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 19 UK Dermatology CRO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 20 Germany Dermatology CRO Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 21 Germany Dermatology CRO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 22 France Dermatology CRO Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 23 France Dermatology CRO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 24 Italy Dermatology CRO Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 25 Italy Dermatology CRO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 26 Spain Dermatology CRO Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 27 Spain Dermatology CRO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 28 Denmark Dermatology CRO Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 29 Denmark Dermatology CRO Market Estimates and Forecasts, by Therapeutics Area, 2021-2033 (USD Million)
Table 30 Sweden Dermatology CRO Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 31 Sweden Dermatology CRO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 32 Norway Dermatology CRO Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 33 Norway Dermatology CRO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 34 Asia-Pacific Dermatology CRO Market Estimates and Forecasts, by Country, 2021-2033 (USD Million)
Table 35 Asia-Pacific Dermatology CRO Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 36 Asia-Pacific Dermatology CRO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 37 Japan Dermatology CRO Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 38 Japan Dermatology CRO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 39 China Dermatology CRO Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 40 China Dermatology CRO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 41 India Dermatology CRO Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 42 India Dermatology CRO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 43 Thailand Dermatology CRO Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 44 Thailand Dermatology CRO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 45 South Korea Dermatology CRO Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 46 South Korea Dermatology CRO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 47 Australia Dermatology CRO Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 48 Australia Dermatology CRO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 49 Latin America Dermatology CRO Market Estimates and Forecasts, by Country, 2021-2033 (USD Million)
Table 50 Latin America Dermatology CRO Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 51 Latin America Dermatology CRO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 52 Brazil Dermatology CRO Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 53 Brazil Dermatology CRO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 54 Argentina Dermatology CRO Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 55 Argentina Dermatology CRO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 56 Middle East & Africa Dermatology CRO Market Estimates and Forecasts, by Country, 2021-2033 (USD Million)
Table 57 Middle East & Africa Dermatology CRO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 58 Middle East & Africa Dermatology CRO Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 59 South Africa Dermatology CRO Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 60 South Africa Dermatology CRO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 61 Saudi Arabia Dermatology CRO Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 62 Saudi Arabia Dermatology CRO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 63 UAE Dermatology CRO Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 64 UAE Dermatology CRO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 65 Kuwait Dermatology CRO Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 66 Kuwait Dermatology CRO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
List of Figures
Figure 1 Market Research Process
Figure 2 Information Procurement
Figure 3 Primary Research Pattern
Figure 4 Market Research Approaches
Figure 5 Market Formulation & Validation
Figure 6 Commodity Flow Analysis
Figure 7 Value-chain Based Sizing & Forecasting
Figure 8 QFD Model Sizing & Forecasting
Figure 9 Bottom-up Approach
Figure 10 Market Snapshot
Figure 11 Segment Snapshot 1
Figure 12 Segment Snapshot 2
Figure 13 Competitive Landscape Snapshot
Figure 14 Parent Market Outlook, 2024 (USD Billion)
Figure 15 Ancillary Market Outlook, 2024 (USD Billion)
Figure 16 Dermatology CRO Market Dynamics
Figure 17 Porter’s Five Forces Analysis
Figure 18 PESTEL Analysis
Figure 19 Dermatology CRO Market: Type Outlook and Key Takeaways
Figure 20 Dermatology CRO Market: Type Movement Analysis
Figure 21 Drug Discovery Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 22 Target Validation Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 23 Lead Identification Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 24 Lead optimization Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 25 Preclinical Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 26 Clinical Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 27 Phase I Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 28 Phase II Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 29 Phase III Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 30 Phase IV Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 31 Dermatology CRO Market: Service Outlook and Key Takeaways
Figure 32 Dermatology CRO Market: Service Movement Analysis
Figure 33 Project Management/Clinical Supply Management Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 34 Data Management Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 35 Regulatory/Medical Affairs Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 36 Medical Writing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 37 Clinical Monitoring Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 38 Quality Management/ Assurance Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 39 Bio-statistics Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 40 Investigator Payments Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 41 Laboratory Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 42 Patient and Site Recruitment Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 43 Technology Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 44 Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 45 Regional Marketplace: Key Takeaways
Figure 46 North America Dermatology CRO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 47 Key country dynamics
Figure 48 U.S. Dermatology CRO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 49 Key country dynamics
Figure 50 Canada Dermatology CRO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 51 Key country dynamics
Figure 52 Mexico Dermatology CRO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 53 Europe Dermatology CRO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 54 Key country dynamics
Figure 55 UK Dermatology CRO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 56 Key country dynamics
Figure 57 Germany Dermatology CRO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 58 Key country dynamics
Figure 59 France Dermatology CRO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 60 Key country dynamics
Figure 61 Italy Dermatology CRO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 62 Key country dynamics
Figure 63 Spain Dermatology CRO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 64 Key country dynamics
Figure 65 Denmark Dermatology CRO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 66 Key country dynamics
Figure 67 Sweden Dermatology CRO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 68 Key country dynamics
Figure 69 Norway Dermatology CRO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 70 Asia-Pacific Dermatology CRO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 71 Key country dynamics
Figure 72 Japan Dermatology CRO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 73 Key country dynamics
Figure 74 China Dermatology CRO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 75 Key country dynamics
Figure 76 India Dermatology CRO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 77 Key country dynamics
Figure 78 Thailand Dermatology CRO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 79 Key country dynamics
Figure 80 South Korea Dermatology CRO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 81 Key country dynamics
Figure 82 Australia Dermatology CRO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 83 Latin America Dermatology CRO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 84 Key country dynamics
Figure 85 Brazil Dermatology CRO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 86 Key country dynamics
Figure 87 Argentina Dermatology CRO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 88 MEA Dermatology CRO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 89 Key country dynamics
Figure 90 South Africa Dermatology CRO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 91 Key country dynamics
Figure 92 Saudi Arabia Dermatology CRO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 93 Key country dynamics
Figure 94 UAE Dermatology CRO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 95 Key country dynamics
Figure 96 Kuwait Dermatology CRO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 97 Key Company Categorization
Figure 98 Service Heat Map Analysis
Figure 99 Strategic Framework

Companies Mentioned

The major companies profiled in this Dermatology CRO market report include:
  • IQVIA Inc.
  • Labcorp Drug Development
  • Thermo Fisher Scientific Inc. (PPD)
  • Parexel International Corp.
  • Parexel International Corp.
  • Charles River Laboratories
  • ICON, Plc
  • Syneos Health
  • Pharmaron
  • Aragen Life Sciences Ltd.
  • Wuxi AppTec
  • Medpace
  • CTI Clinical Trial & Consulting
  • Bioskin
  • Proinnovera GmbH
  • Biorasi, LLC

Table Information

Report AttributeDetails
No. of Pages120
PublishedAugust 2025
Forecast Period2024 - 2033
Estimated Market Value ( USD ) in 2024 $ 5.42 Billion
Forecasted Market Value ( USD ) by 2033 $ 9.09 Billion
Compound Annual Growth Rate5.8%
Regions CoveredGlobal
No. of Companies Mentioned17

Related Topics

Related Reports

Dermatology Contract Research Organization (CRO) - Global Strategic Business Report - Product Image

Dermatology Contract Research Organization (CRO) - Global Strategic Business Report

  • Report
  • 300 Pages
  • Global
From
Cell & Gene Therapy Contract Research Organizations Market Size, Share & Trends Analysis Report By Type (Drug Discovery, Preclinical, Clinical), By Service (Regulatory Strategy, Clinical Monitoring), By Indication, By Modality, By Region, And Segment Forecasts, 2025 - 2033 - Product Image

Cell & Gene Therapy Contract Research Organizations Market Size, Share & Trends Analysis Report By Type (Drug Discovery, Preclinical, Clinical), By Service (Regulatory Strategy, Clinical Monitoring), By Indication, By Modality, By Region, And Segment Forecasts, 2025 - 2033

  • Report
  • 150 Pages
  • Global
From
In-vivo CRO Market Report by Type, GLP Type, Indication, and Region 2025-2033 - Product Image

In-vivo CRO Market Report by Type, GLP Type, Indication, and Region 2025-2033

  • Report
  • 146 Pages
  • Global
From
Contract Research Organization (CRO) Services Market by Type (Early Phase, Clinical, Lab, Consulting), Therapeutic Area (Cancer (Breast, Lung), Infectious, Neurology, Vaccines), Modality (Small Molecules, Biologics, Biosimilars) - Global Forecast to 2030 - Product Image

Contract Research Organization (CRO) Services Market by Type (Early Phase, Clinical, Lab, Consulting), Therapeutic Area (Cancer (Breast, Lung), Infectious, Neurology, Vaccines), Modality (Small Molecules, Biologics, Biosimilars) - Global Forecast to 2030

  • Report
  • 634 Pages
  • Global
From
Oncology Based in-Vivo CRO Market Report by Indication, Model, Application, and Region 2025-2033 - Product Image

Oncology Based in-Vivo CRO Market Report by Indication, Model, Application, and Region 2025-2033

  • Report
  • 148 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.